CNR Institutional Research Information System

FEDELE, MONICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 31
AS - Asia 28
NA - Nord America 1
Totale 60
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 31
KR - Corea 18
CN - Cina 7
SG - Singapore 3
US - Stati Uniti d'America 1
Totale 60
Salva come PNG Salva come JPEG
Città #
Naples 27
Seoul 18
Aversa 2
Singapore 2
Forest City 1
Totale 50
Salva come PNG Salva come JPEG
Nome #
Novel Aptamers Selected on Living Cells for Specific Recognition of Triple-Negative Breast Cancer 6
Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer 6
null 6
The Transcription Regulator Patz1 Is Essential for Neural Stem Cell Maintenance and Proliferation 5
null 4
Selective Photo-Assisted Eradication of Triple-Negative Breast Cancer Cells through Aptamer Decoration of Doped Conjugated Polymer Nanoparticles 4
null 4
AI identifies potent inducers of breast cancer stem cell differentiation based on adversarial learning from gene expression data 4
Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies 3
The Epithelial–Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression 3
PATZ1 in Non-Small Cell Lung Cancer: A New Biomarker That Negatively Correlates with PD-L1 Expression and Suppresses the Malignant Phenotype 3
Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells 3
Epithelial–Mesenchymal Transition (EMT) 2021 3
Optimization of Short RNA Aptamers for TNBC Cell Targeting 3
Aptamer-mediated impairment of EGFR-integrin alpha v beta 3 complex inhibits vasculogenic mimicry and growth of triple-negative breast cancers 2
Metabolic Reprogramming in Thyroid Cancer: Role of the Epithelial-Mesenchymal Transition 2
Subtype Transdifferenziation in Human Cancer: The Power of Tissue Plasticity in Tumor Progression 2
Epithelial–Mesenchymal Transition (EMT) 2
Role of Diet in Stem and Cancer Stem Cells 2
Mechanism of Action of Lactic Acid on Histones in Cancer 2
PATZ and BCL-6 oncogene cooperate in transcriptional repression 2
The Genetics of Pituitary Adenomas 2
The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis. 2
Aptamers and antibodies: rivals or allies in cancer targeted therapy? 2
Animal Models of Human Pathology 2020 2
Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer Cells 2
Transgenic mice overexpressing the HMGI-C wild-type gene develop pituitary adenomas. 2
Aptamer-Based Strategies to Boost Immunotherapy in TNBC 2
Altered MicroRNA Expression Profile in Human Pituitary GH Adenomas: Down-Regulation of miRNA Targeting HMGA1, HMGA2, and E2F1 1
Suppression of transformation by inhibition of HMGI-C protein synthesis: regulatory changes of NF-kB and AP-1 transcription factors. 1
PIT1 upregulation by HMGA proteins has a role in pituitary tumorigenesis. 1
The dosage of Patz1 modulates reprogramming process 1
Hmga1 null mice are less susceptible to chemically induced skin carcinogenesis. 1
PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration 1
Tumor suppressor activity of CBX7 in lung carcinogenesis. 1
PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas 1
Proneural-mesenchymal transition: Phenotypic plasticity to acquire multitherapy resistance in glioblastoma 1
Hmga1/Hmga2 double knock-out mice display a "superpygmy" phenotype. 1
Dual Oncogenic/Anti-Oncogenic Role of PATZ1 in FRTL5 Rat Thyroid Cells Transformed by the Ha-Ras(V12) Oncogene 1
HMGA2 cooperates with either p27 deficiency or Cdk4 mutation in pituitary tumorigenesis. 1
La trasformazione neoplastica di cellule tiroidee di ratto è associata a cambiamenti nell'attività del complesso trascrizionale AP-1. 1
High mobility group A-interacting proteins in cancer: focus on chromobox protein homolog 7, homeodomain interacting protein kinase 2 and PATZ 1
CBX7 is a tumor suppressor in mice and humans 1
E2F1 activation is responsible for pituitary adenoma induced by HMGA2 gene overexpression 1
Chromobox protein homologue 7 protein, with decreased expression in human carcinomas, positively regulates E-cadherin expression by interacting with the histone deacetylase 2 protein. 1
Onset of Natural Killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway. 1
PATZ, a BTB/POZ domain zinc-finger protein, is a potencial target of the BCL-6 oncogene 1
Embryonic defects and growth alteration in mice with homozygous disruption of the Patz1 gene. 1
Thyroid differentiation is blocked by a mutated p53 gene. 1
Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas. 1
Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway. 1
Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines 1
Critical role of the HMGI(Y) proteins in adipocytic cell growth and differentiation. 1
HMGA1 protein expression sensitizes cells to cisplatin-induced cell death. 1
Complementary actions of dopamine D2 receptor agonist and anti-vegf therapy on tumoral vessel normalization in a transgenic mouse model 1
Overexpression of proteins HMGA1 induces cell cycle deregulation and apoptosis in normal rat thyroid cells. 1
Pituitary adenoma: Role of HMGA proteins 1
Simian virus 40-like DNA sequences in human papillary thyroid carcinomas 1
HMGA and cancer. 1
Overexpression of HMGI(Y) proteins induces apoptosis in normal PC Cl 3 cells. 1
Detection of High Mobility Group I HMGI(Y) Protein in the Diagnosis of Thyroid Tumors: HMGI(Y) Expression Represents a Potential Diagnostic Indicator of Carcinoma 1
FRA-1 expression in hyperplastic and neoplastic thyroid diseases. 1
TNBC Challenge: Oligonucleotide Aptamers for New Imaging and Therapy Modalities 1
HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity. 1
Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice 1
SOM230, a new somatostatin analog, is highly effective in the therapy of GH/PRL-secreting pituitary adenomas spontaneously developing in transgenic mice overexpressing the HMGA2 gene 1
Animal models of human pathology 2013 1
Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts 1
Totale 125
Salva come PNG Salva come JPEG
Categoria #
all - tutte 1.413
article - articoli 1.116
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 54
Totale 2.583
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202498 0 0 0 0 0 0 0 0 27 0 31 40
2024/202527 27 0 0 0 0 0 0 0 0 0 0 0
Totale 125